Background Molecular signatures may become of use in clinical practice to assess the prognosis of breast cancers. However, although international consensus conferences sustain the use of these new mar

NIAID Data Ecosystem30

Additional file 2 of Prognostic biomarkers related to breast cancer recurrence identified based on Logit model analysis

乳腺癌预后

生物标志物

Additional file 2: Table 2. Histopathological data from GSE45725 dataset cases.

Figshare2020-09-25 更新20

Decision impact by EPclin vs. uPA/PAI-1.

资源简介：

相关数据集